MR imaging demonstration of a recurrent breast cancer following deep inferior epigastric perforator (DIEP) flap reconstruction

2006 ◽  
Vol 59 (1) ◽  
pp. 31-34 ◽  
Author(s):  
Caroline Caramella ◽  
Alain Luciani ◽  
Thu Ha Dao ◽  
Laurent Lantieri ◽  
Laurent Zelek ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Recurrent Breast Cancer ◽  
Diep Flap ◽  
Flap Reconstruction ◽  
Deep Inferior Epigastric Perforator ◽  
Recurrent Breast

Full-Thickness Resection With Myocutaneous Flap Reconstruction for Locally Recurrent Breast Cancer

2008 ◽  
Vol 85 (6) ◽  
pp. 1894-1900 ◽  
Author(s):  
Godehard Friedel ◽  
Thomas Kuipers ◽  
Jürgen Dippon ◽  
Fawaz Al-Kammash ◽  
Thorsten Walles ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Myocutaneous Flap ◽  
Recurrent Breast Cancer ◽  
Full Thickness ◽  
Flap Reconstruction ◽  
Locally Recurrent ◽  
Recurrent Breast

Recurrent breast cancer after conservative surgery: Role of contrast enhanced MR imaging

1998 ◽  
Vol 34 ◽  
pp. S76
Author(s):  
M.L Grandinetti ◽  
F.R. Ferranti ◽  
E. Saracca ◽  
I. Ventura ◽  
C. Nistico' ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Conservative Surgery ◽  
Recurrent Breast Cancer ◽  
Contrast Enhanced ◽  
Recurrent Breast

Detection of Recurrent Breast Cancer After TRAM Flap Reconstruction

2001 ◽  
Vol 47 (6) ◽  
pp. 602-607 ◽  
Author(s):  
Nina Shaikh ◽  
Gregory LaTrenta ◽  
Alexander Swistel ◽  
Michael Osborne
Keyword(s):  
Breast Cancer ◽  
Recurrent Breast Cancer ◽  
Tram Flap ◽  
Flap Reconstruction ◽  
Recurrent Breast

ER, PR & HER2 Receptor status in recurrent breast cancer: Its relation to age & time of recurrence

2020 ◽  
Vol 22 (1) ◽  
pp. 16-20
Author(s):  
Abu Khaled Muhammad Iqbal ◽  
Nasima Akhter ◽  
Hasan Shahrear Ahmed ◽  
Md Rassell ◽  
AMM Yahia ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Treatment Approach ◽  
Recurrent Breast Cancer ◽  
Breast Cancer Patients ◽  
Her2 Receptor ◽  
Younger Patients ◽  
Receptor Status ◽  
Increased Risk ◽  
Neoplastic Lesions ◽  
Recurrent Breast

Background: Malignant neoplastic lesions of the breast are one of the main causes of cancer death among women. In tumor cells the expression status of Estrogen receptor (ER), progesterone receptor (PR), and c-ERBB2 (HER2/neu) are therapeutically and prognostically important markers affecting the treatment approach, management and prognosis of breast carcinoma. Objective: To explore the relation of receptor status in recurrent breast cancer to age and time of recurrence. Methods: This study was conducted in National Institute of Cancer Research and Hospital (NICRH) and included 81 female patients between 20 to 75 years with recurrent breast cancer. Detection of receptor status of ER +ve/-ve, PR +ve/-ve, Her-2+ve/-ve was based on the immunohistochemistry staining of tissue samples of malignant neoplastic lesions prepared from tissue biopsies of patients with recurrent breast cancer. All the information were recorded through the pre-structured data collection sheet and analyzed. Results: This study showed that most of the recurrent breast cancer patients were Triple negative breast cancer (TNBC) (39.5%) and among them most of them were younger patients. Younger patients with TNBC had increased risk of recurrence. Most of the recurrence occurred within 1-2 years. Conclusion: It can be concluded that the assessment of the expression of these biornarkers in recurrent tumors provides reliable information for the treatment approach of locoregional tumors. Journal of Surgical Sciences (2018) Vol. 22 (1): 16-20

Sign in / Sign up

Export Citation Format

Share Document